SGLT-2 Inhibitor

Administration
  • Type: Oral Diabetes medication
  • Canagliflozin (Invokana), Dapagliflozin (Farxiga), Empagliflozin (Jardiance) are FDA approved for use in type 2 diabetes

Contraindications
  • Allergy to class/drug

Adverse Reactions

Serious

Common
  • UTI
  • Genital candidiasis
  • Weight loss
  • Dehydration/Orthostasis

Mechanism of Action
  • Inhibit sodium-glucose cotransporter 2, decreasing glucose reabsorption in the proximal tubule

References
  1. FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
This article is issued from Wikem. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.